Navigation Links
Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program

Educational program offers unique resources to empower transplant patients

and their caregivers

DEERFIELD, Ill., Oct. 17 /PRNewswire-FirstCall/ -- Astellas Pharma US, Inc. (Pink Sheets: ALPMF), a leader in the field of transplantation, and The International Transplant Nurses Society (ITNS), a leading transplant professional organization, announced a collaborative partnership to jointly develop further materials for the multi-award-winning Transplant Experience program -- a comprehensive, educational resource for the transplant community.

"The International Transplant Nurses Society (ITNS) endorses the Transplant Experience program and is proud to be a collaborative partner with Astellas," said Beth A. Kassalen, Executive Director of ITNS. "We are excited to be able to develop materials that empower organ transplant recipients and their caregivers to take a more active role in their treatment and long-term health."

The Transplant Experience program offers a variety of tools to help empower patients and caregivers, providing resources throughout every stage of the transplant experience: pre-transplant, the first year after a transplant, and beyond. The program includes, tools, tips and also provides peer-to-peer information from transplant recipients. Materials are available at or by calling 1-800-466-9191, and include:

-- Welcome kit, including an inspirational video, a personal treatment

journal and a unique pill box to help patients organize and carry their


-- Helpful information sent directly to patients throughout the year,

including newsletters, emails, videos, special gifts and more

-- Regular updates on news and events in the transplant community

-- Shared stories of challenges and successes

-- Tools and advice to help patients achieve long-term health

"Educating the patient community and sharing scientific knowledge with healthcare professionals, such as transplant nurses, is Astellas' responsibility as a leader in the field of transplantation," said M. Roy First, M.D., Vice President, Global Immunology, Astellas Pharma US, Inc. "This partnership further strengthens our relationship with the transplant community and provides vital information to patients and caregivers about the transplant experience."

The first piece developed jointly by ITNS and Astellas is a brochure, "Kidney Function and Your New Organ," available both in a hard copy format, and a downloadable version through

About ITNS

The International Transplant Nurses Society was founded in 1992 as the first professional nursing organization to promote the education and clinical practice excellence of nurses caring for solid organ transplant patients. Today, ITNS is a leading transplant organization with more than 1,400 active members representing 29 countries around the world.

A vital component of countless nursing careers, ITNS provides a forum for learning about the most current advances in transplantation and transplant patient care. Over the years ITNS has provided skilled transplant nurses the opportunity to share and learn with national and international peers and to receive recognition for their knowledge, leadership, and scholarly pursuits.

About Astellas

Astellas is a recognized leader in transplantation and has been committed to the field of immunology for more than 20 years. Dedicated to supporting the advancement of care for patients, Astellas continues to build upon its legacy and leadership in transplantation by investing in ongoing clinical research and new product development.

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc., Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, inc., please visit our website at

SOURCE Astellas Pharma US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
(Date:11/24/2015)... --> --> ... Synthesis Market by Product & Services (Primer, Probe, Custom ... RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - ... is expected to reach USD 1,918.6 Million by 2020 ... of 10.1% during the forecast period. Browse ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
(Date:11/24/2015)... ... ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and ... as Chief Operating Officer. , Having joined InSphero in November 2013 as ... promoted to Head of InSphero Diagnostics in 2014. There she has built up ...
Breaking Biology Technology:
(Date:11/12/2015)... Nov. 12, 2015  Arxspan has entered into ... and Harvard for use of its ArxLab cloud-based ... tools. The partnership will support the institute,s efforts ... chemical research information internally and with external collaborators. ... for managing the Institute,s electronic laboratory notebook, compound ...
(Date:11/11/2015)...   MedNet Solutions , an innovative SaaS-based eClinical technology ... pleased to announce that it will be a Sponsor of ... to be held November 17-19 in Hamburg ... of iMedNet , MedNet,s easy-to-use, proven and ... has been able to deliver time and cost savings of ...
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
Breaking Biology News(10 mins):